The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers

Miklós Németh, László Virág, Ottó Hála, András Varró, Gábor Kovács, Dirk Thormählen, Julius Gyula Papp

Research output: Contribution to journalArticle

20 Citations (Scopus)


The cellular electrophysiological effects of 1 μM tedisamil (KC 8857) were studied in human atrial and ventricular fibers. Conventional microelectrode technique was applied to record the transmembrane action potentials at stimulation frequency of 100 per min and 37°C. Tedisamil lengthened action potential duration (APD) more in atrial than in ventricular muscle fibers; prolongation of APD90 was 28.9±3.3% (n=6; p<0.05) for atrial and 13.3±5.2% (n=6; P<0.05) for ventricular tissue. The maximal rate of depolarization was depressed slightly, but significantly by 1 μM tedisamil only in ventricular fibers (12.9±6.5%, n = 6, P < 0.05). From these cellular electrophysiological data it is concluded that the bradycardic/antiischemic agent tedisamil possesses marked Class III properties not only in cardiac tissues of experimental animals but also those of man.

Original languageEnglish
Pages (from-to)246-248
Number of pages3
JournalCardiovascular research
Issue number2
Publication statusPublished - Feb 1 1996



  • Anti-arrhythmia drugs
  • Human, atrium
  • Human, ventricle
  • KC 8857
  • Membrane potential
  • Tedisamil

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this